Cargando…
Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample
BACKGROUND: Despite its approval for use in acute ischemic stroke (AIS) >25 years ago, intravenous thrombolysis (IVT) remains underutilized, with inequities by age, sex, race/ethnicity, and geography. Little is known about IVT rates by insurance status. We aimed to assess temporal trends in the i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592994/ https://www.ncbi.nlm.nih.gov/pubmed/37873114 http://dx.doi.org/10.1101/2023.10.09.23296783 |
_version_ | 1785124375598465024 |
---|---|
author | Sun, Philip Zheng, Ling Lin, Michelle Cen, Steven Hammond, Gmerice Joynt Maddox, Karen E. Kim-Tenser, May Sanossian, Nerses Mack, William Towfighi, Amytis |
author_facet | Sun, Philip Zheng, Ling Lin, Michelle Cen, Steven Hammond, Gmerice Joynt Maddox, Karen E. Kim-Tenser, May Sanossian, Nerses Mack, William Towfighi, Amytis |
author_sort | Sun, Philip |
collection | PubMed |
description | BACKGROUND: Despite its approval for use in acute ischemic stroke (AIS) >25 years ago, intravenous thrombolysis (IVT) remains underutilized, with inequities by age, sex, race/ethnicity, and geography. Little is known about IVT rates by insurance status. We aimed to assess temporal trends in the inequities in IVT use. METHODS: We assessed trends from 2002 to 2015 in IVT for AIS in the Nationwide Inpatient Sample by sex, age, race/ethnicity, hospital location/teaching status, and insurance, using survey-weighted logistic regression, adjusting for sociodemographics, comorbidities, and hospital characteristics. We calculated odds ratios for IVT for each category in 2002–2008 (Period 1) and 2009–2015 (Period 2). RESULTS: Among AIS patients (weighted N=6,694,081), IVT increased from 1.0% in 2002 to 6.8% in 2015 (adjusted annual relative ratio (AARR) 1.15, 95% CI 1.14–1.16). Individuals ≥85 years had the most pronounced increase from 2002 to 2015 (AARR 1.18, 1.17–1.19), but were less likely to receive IVT compared to those aged 18–44 years in both Period 1 (adjusted odds ratio (aOR) 0.23, 0.21–0.26) and Period 2 (aOR 0.36, 0.34–0.38). Women were less likely than men to receive IVT, but the disparity narrowed over time (Period 1 aOR 0.81, 0.78–0.84, Period 2 aOR 0.94, 0.92–0.97). Inequities in IVT by race/ethnicity resolved for Hispanic individuals in Period 2 but not for Black individuals (Period 2 aOR 0.81, 0.78–0.85). The disparity in IVT for Medicare patients, compared to privately insured patients, lessened over time (Period 1 aOR 0.59, 0.56–0.52, Period 2 aOR 0.75, 0.72–0.77). Patients treated in rural hospitals were less likely to receive IVT than those treated in urban hospitals; a more dramatic increase in urban areas widened the inequity (Period 2 urban non-teaching vs. rural aOR 2.58, 2.33–2.85, urban teaching vs. rural aOR 3.90, 3.55–4.28). CONCLUSION: From 2002 through 2015, IVT for AIS increased among adults. Despite encouraging trends, only 1 in 15 AIS patients received IVT and persistent inequities remained for Black individuals, women, government-insured, and those treated in rural areas, highlighting the need for intensified efforts at addressing inequities. |
format | Online Article Text |
id | pubmed-10592994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-105929942023-10-24 Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample Sun, Philip Zheng, Ling Lin, Michelle Cen, Steven Hammond, Gmerice Joynt Maddox, Karen E. Kim-Tenser, May Sanossian, Nerses Mack, William Towfighi, Amytis medRxiv Article BACKGROUND: Despite its approval for use in acute ischemic stroke (AIS) >25 years ago, intravenous thrombolysis (IVT) remains underutilized, with inequities by age, sex, race/ethnicity, and geography. Little is known about IVT rates by insurance status. We aimed to assess temporal trends in the inequities in IVT use. METHODS: We assessed trends from 2002 to 2015 in IVT for AIS in the Nationwide Inpatient Sample by sex, age, race/ethnicity, hospital location/teaching status, and insurance, using survey-weighted logistic regression, adjusting for sociodemographics, comorbidities, and hospital characteristics. We calculated odds ratios for IVT for each category in 2002–2008 (Period 1) and 2009–2015 (Period 2). RESULTS: Among AIS patients (weighted N=6,694,081), IVT increased from 1.0% in 2002 to 6.8% in 2015 (adjusted annual relative ratio (AARR) 1.15, 95% CI 1.14–1.16). Individuals ≥85 years had the most pronounced increase from 2002 to 2015 (AARR 1.18, 1.17–1.19), but were less likely to receive IVT compared to those aged 18–44 years in both Period 1 (adjusted odds ratio (aOR) 0.23, 0.21–0.26) and Period 2 (aOR 0.36, 0.34–0.38). Women were less likely than men to receive IVT, but the disparity narrowed over time (Period 1 aOR 0.81, 0.78–0.84, Period 2 aOR 0.94, 0.92–0.97). Inequities in IVT by race/ethnicity resolved for Hispanic individuals in Period 2 but not for Black individuals (Period 2 aOR 0.81, 0.78–0.85). The disparity in IVT for Medicare patients, compared to privately insured patients, lessened over time (Period 1 aOR 0.59, 0.56–0.52, Period 2 aOR 0.75, 0.72–0.77). Patients treated in rural hospitals were less likely to receive IVT than those treated in urban hospitals; a more dramatic increase in urban areas widened the inequity (Period 2 urban non-teaching vs. rural aOR 2.58, 2.33–2.85, urban teaching vs. rural aOR 3.90, 3.55–4.28). CONCLUSION: From 2002 through 2015, IVT for AIS increased among adults. Despite encouraging trends, only 1 in 15 AIS patients received IVT and persistent inequities remained for Black individuals, women, government-insured, and those treated in rural areas, highlighting the need for intensified efforts at addressing inequities. Cold Spring Harbor Laboratory 2023-10-10 /pmc/articles/PMC10592994/ /pubmed/37873114 http://dx.doi.org/10.1101/2023.10.09.23296783 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Sun, Philip Zheng, Ling Lin, Michelle Cen, Steven Hammond, Gmerice Joynt Maddox, Karen E. Kim-Tenser, May Sanossian, Nerses Mack, William Towfighi, Amytis Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title | Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title_full | Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title_fullStr | Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title_full_unstemmed | Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title_short | Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample |
title_sort | persistent inequities in intravenous thrombolysis for acute ischemic stroke in the united states: results from the nationwide inpatient sample |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592994/ https://www.ncbi.nlm.nih.gov/pubmed/37873114 http://dx.doi.org/10.1101/2023.10.09.23296783 |
work_keys_str_mv | AT sunphilip persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT zhengling persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT linmichelle persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT censteven persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT hammondgmerice persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT joyntmaddoxkarene persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT kimtensermay persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT sanossiannerses persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT mackwilliam persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample AT towfighiamytis persistentinequitiesinintravenousthrombolysisforacuteischemicstrokeintheunitedstatesresultsfromthenationwideinpatientsample |